Thank you to our distinguished speakers for their inspiring presentations throughout the years. Our diverse speakers are located across the U.S. and are selected by our Trudeau Society Steering Committee for their innovative research, best practices in patient care, and their immense work in improving lung health in our communities.
Toby Maher, M.D., is Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine, University of Southern California, Los Angeles. He has spent the last 15 years specializing in the management of all forms of pulmonary fibrosis and orphan interstitial lung diseases.
He previously ran the ILD unit at Royal Brompton Hospital, London seeing more than 1500 new ILD patients per year. Since June 2020 he has been Director of ILD at Keck Medicine of USC. His research interests include; biomarker discovery, the lung microbiome and host immune response in the pathogenesis of IPF and clinical trials in interstitial lung disease. He has been involved in >50 trials in fibrotic lung disease from phase 1b through to phase 4 and including those assessing IPF, scleroderma, rheumatoid arthritis and inflammatory myositis. Overall, he has recruited > 1000 patients into interventional studies. He has given expert opinion to FDA and EMA. He is an associate editor for American Journal of Respiratory and Critical Care Medicine and has authored over 270 papers and book chapters on pulmonary fibrosis
Jonathan Corren, M.D., has been a faculty member in the departments of Medicine and Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles, since 1991 and is currently actively involved in allergy and immunology education at the university.
He is also medical director of a private practice in Allergy/Immunology and research director of a clinical research site which focusses upon severe asthma, chronic rhinosinusitis, allergy immunotherapy, immunodeficiencies, and allergic skin diseases.
He is currently project chair for a multi-center trial evaluating the immunologic and clinical effects of allergen-specific immunotherapy combined with an inhibitor of thymic stromic lymphopoietin. He is also a consultant regarding clinical study design with multiple pharmaceutical companies, including AstraZeneca, Genentech, Novartis, Regeneron, and Sanofi.
Dr. Soo Hoo is a Health Sciences Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA and is also the Acting Chief of the Pulmonary and Critical Care Section and Director, Pulmonary and Critical Care Unit at the West Los Angeles VA Healthcare Center.
He has been at the VA since 1989 and has a research interest in non-invasive ventilation, as well as non-pharmacologic treatment of Chronic Obstructive Pulmonary Disease. He is a Board member of BREATHE California of Los Angeles as well as past Chairman of the Board on two occasions. He has participated in World COPD day since its inception in 2010.
Dr. Soo Hoo has been involved with the care of patients with smoking related conditions during his entire professional career. More recently, he has collaborated on multisite investigations of patients with human immuno-deficiency virus (HIV) infection and effects on Chronic Obstructive Pulmonary Disease and lung cancer. In addition to academic investigations, he has also been involved with VA wide patient care projects in healthcare delivery, most recently in tele-spirometry programs and along with a comprehensive treatment program for patients with COPD including pulmonary rehabilitation, advanced bronchoscopic therapies and lung transplantation.
Dr. Reilly is a Professor of Family Medicine at the Keck School of Medicine of USC (KSOM). She is the Director of the Keck School of Medicine of USC Primary Care Initiative, Associate Director of the KSOM Introduction to Clinical Medicine Course and KSOM Family Medicine Pre- Doctoral Director.
She graduated from Georgetown Medical School, completed her internship and residency in Family Medicine at the Kaiser Permanente Family Residency Program in Los Angeles and her fellowship in Women’s Health and Obstetrics at the White Memorial Family Practice Residency Program where she remained as faculty for 13 years.
She is the Chair of the American Academy of Family Physician’s commission on Education, Student and Resident Subcommittee, on the Editorial Boards of Family Medicine, Family Systems and Health and PULSE, the KSOM senior Family Medicine Student Advisor and on the leadership team of the Society of Teacher’s of Family Medicine’s Bioethics and Humanities Interest Group. Dr. Reilly’s publications and research interests include innovations in student and resident education, physician well-being, care for the underserved, arts, preventative medicine, humanities, narrative medicine, and women and children’s health care.
Dr. Tiep is a seasoned pulmonologist who is distinguished amongst his peers and associates and has been the recipient of many prestigious awards and recognition throughout his celebrated career as a physician.
Dr. Tiep is the author of an immense body of peer reviewed original abstracts, articles, reviews and contributions in the area of pulmonary medicine. He has served on the Editorial Boards of respiratory journals and has presented various topics at scientific conferences, nationally and internationally. He has developed several patents in the area of oxygen therapy and developed the Respiratory Disease Management Institute and Pulmonary Rehabilitation programs that support the treatment and management of patients from post-acute care through end of life at City of Hope Medical Center.
Dr. Tiep has participated in leadership roles with many organizations and is well versed on the diagnosis, treatment and management of patients throughout the continuum of care.
Dr. Falk received his medical degree at the Ohio State University College of Medicine in 1998. He completed his residency, chief residency, and Pulmonary and Critical Care fellowship at Temple University.
He joined the faculty at Cedars-Sinai Medical Center in 2006. He currently serves as the Fellowship Program Director as well as the Associate Director of Lung Transplant. His clinical and research interests include pulmonary fibrosis, COPD, alpha-one antitrypsin deficiency and lung transplant.
Dr. Tashkin is Emeritus Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the David Geffen School of Medicine at the University of California Los Angeles (UCLA).
Medical Board Certifications
Internal Medicine, American Board of Internal Medicine, 2015 Pulmonary Disease, American Board of Internal Medicine, 2018 Critical Care Medicine, American Board of Internal Medicine, 2019